The intellectual base and global trends in contrast-induced acute kidney injury: a bibliometric analysis

References

• Tao SM, Wichmann JL, Schoepf UJ, et al. Contrast-induced nephropathy in CT: incidence, risk factors and strategies for prevention. Eur Radiol. 2016;26(9):3310–3318.
   PubMed Web of Science ®Google Scholar
• Wong GTC, Lee EYP, Irwin MG. Contrast induced nephropathy in vascular surgery. Br J Anaesth. 2016;117:ii63–ii73.
   PubMed Web of Science ®Google Scholar
• Betoko A, Matheson MB, Ostovaneh MR, et al. Acute kidney injury after repeated exposure to contrast material for coronary angiography. Mayo Clin Proc Innov Qual Outcomes. 2021;5(1):46–54.
   PubMedGoogle Scholar
• Fähling M, Seeliger E, Patzak A, et al. Understanding and preventing contrast-induced acute kidney injury. Nat Rev Nephrol. 2017;13(3):169–180.
   PubMed Web of Science ®Google Scholar
• Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–830.
   PubMed Web of Science ®Google Scholar
• Lameire N, Kellum JA. Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (part 2). Crit Care. 2013;17(1):205.
   PubMed Web of Science ®Google Scholar
• Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39(5):930–936.
   PubMed Web of Science ®Google Scholar
• Morcos R, Kucharik M, Bansal P, et al. Contrast-induced acute kidney injury: review and practical update. Clin Med Insights Cardiol. 2019;13:1179546819878680.
   Web of Science ®Google Scholar
• Lakhal K, Robert-Edan V, Ehrmann S. In the name of contrast-induced acute kidney injury. Chest. 2020;157(4):751–752.
   PubMed Web of Science ®Google Scholar
• Xu Z, Zhang Y, Zhang C, et al. Clinical features and outcomes of COVID-19 patients with acute kidney injury and acute kidney injury on chronic kidney disease. Aging Dis. 2022;13(3):884–898.
   PubMedGoogle Scholar
• Abdalla MA, Ahmed KO, Yousef BA. Incidence and risk factors of contrast-induced acute kidney injury in Sudanese patients undergoing coronary angiography: a descriptive prospective study. Cureus. 2022;14(2):e21876.
   PubMed Web of Science ®Google Scholar
• Husain-Syed F, Rosner MH, Ronco C. Distant organ dysfunction in acute kidney injury. Acta Physiol. 2020;228(2):e13357.
   PubMed Web of Science ®Google Scholar
• Kusirisin P, Chattipakorn SC, Chattipakorn N. Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches. J Transl Med. 2020;18(1):400.
   PubMed Web of Science ®Google Scholar
• Bansal S, Patel RN. Pathophysiology of contrast-induced acute kidney injury. Interv Cardiol Clin. 2020;9(3):293–298.
   PubMedGoogle Scholar
• Faucon AL, Bobrie G, Clement O. Nephrotoxicity of iodinated contrast media: from pathophysiology to prevention strategies. Eur J Radiol. 2019;116:231–241.
   PubMed Web of Science ®Google Scholar
• Ma C, Chen T, Ti Y, et al. Ranolazine alleviates contrast-associated acute kidney injury through modulation of calcium independent oxidative stress and apoptosis. Life Sci. 2021;267:118920.
   PubMed Web of Science ®Google Scholar
• Yang KJ, Kim JH, Chang YK, et al. Inhibition of xanthine oxidoreductase protects against contrast-induced renal tubular injury by activating adenosine monophosphate-activated protein kinase. Free Radic Biol Med. 2019;145:209–220.
   PubMed Web of Science ®Google Scholar
• Williams AR, Wiggins RC, Wharram BL, et al. Nephron injury induced by diagnostic ultrasound imaging at high mechanical index with gas body contrast agent. Ultrasound Med Biol. 2007;33(8):1336–1344.
   PubMed Web of Science ®Google Scholar
• Moore JK, Chen J, Pan H, et al. Quantification of vascular damage in acute kidney injury with fluorine magnetic resonance imaging and spectroscopy. Magn Reson Med. 2018;79(6):3144–3153.
   PubMed Web of Science ®Google Scholar
• Ghumman SS, Weinerman J, Khan A, et al. Contrast induced-acute kidney injury following peripheral angiography with carbon dioxide versus iodinated contrast media: a meta-analysis and systematic review of current literature. Catheter Cardiovasc Interv. 2017;90(3):437–448.
   PubMed Web of Science ®Google Scholar
• van der Molen AJ, Reimer P, Dekkers IA, et al. Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients: recommendations for updated ESUR contrast medium safety committee guidelines. Eur Radiol. 2018;28(7):2856–2869.
   PubMed Web of Science ®Google Scholar
• Ward DB, Valentovic MA. Contrast induced acute kidney injury and direct cytotoxicity of iodinated radiocontrast media on renal proximal tubule cells. J Pharmacol Exp Ther. 2019;370(2):160–171.
   PubMed Web of Science ®Google Scholar
• Sugimoto CR, Ahn Y-Y, Smith E, et al. Factors affecting sex-related reporting in medical research: a cross-disciplinary bibliometric analysis. Lancet. 2019;393(10171):550–559.
   PubMed Web of Science ®Google Scholar
• Martin-Martin A, Thelwall M, Orduna-Malea E, et al. Google Scholar, Microsoft Academic, Scopus, Dimensions, Web of Science, and OpenCitations’ COCI: a multidisciplinary comparison of coverage via citations. Scientometrics. 2021;126(1):871–906.
   PubMed Web of Science ®Google Scholar
• Chen C, CiteSpace II. Detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inform Sci Technol. 2006;57(3):359–377.
   Web of Science ®Google Scholar
• van Eck NJ, Waltman L. Citation-based clustering of publications using CitNetExplorer and VOSviewer. Scientometrics. 2017;111(2):1053–1070.
   PubMed Web of Science ®Google Scholar
• Tan L, Wang X, Yuan K, et al. Structural and temporal dynamics analysis on drug-eluting stents: history, research hotspots and emerging trends. Bioact Mater. 2023;23:170–186.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang Q, Hu J, et al. Global research trends in in-stent neoatherosclerosis: a CiteSpace-based visual analysis. Front Cardiovasc Med. 2022;9:1025858.
   PubMed Web of Science ®Google Scholar
• Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–c184.
   PubMedGoogle Scholar
• Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124(23):2574–2609.
   PubMed Web of Science ®Google Scholar
• Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393–1399.
   PubMed Web of Science ®Google Scholar
• Aboyans V, Ricco JB, Bartelink ML, et al. [2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)]. Kardiol Pol. 2017;75(11):1065–1160.
   PubMedGoogle Scholar
• Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1). Crit Care. 2013;17(1):204.
   PubMed Web of Science ®Google Scholar
• Kushner FG, Hand M, Smith SC Jr., et al. 2009 Focused updates: ACC/AHA guidelines for the management of patients with ST-Elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2009;120(22):2271–2306.
   PubMed Web of Science ®Google Scholar
• Kushner FG, Hand M, Smith SC Jr., et al. 2009 Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2009;54(23):2205–2241.
   PubMed Web of Science ®Google Scholar
• KDOQI. Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49(2 Suppl 2):S12–S154.
   PubMed Web of Science ®Google Scholar
• Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380(9843):756–766.
   PubMed Web of Science ®Google Scholar
• Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004;291(19):2328–2334.
   PubMed Web of Science ®Google Scholar
• Nijssen EC, Rennenberg RJ, Nelemans PJ, et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet. 2017;389(10076):1312–1322.
   PubMed Web of Science ®Google Scholar
• Briguori C, Airoldi F, D'Andrea D, et al. Renal insufficiency following contrast media administration trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation. 2007;115(10):1211–1217.
   PubMed Web of Science ®Google Scholar
• McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008;51(15):1419–1428.
   PubMed Web of Science ®Google Scholar
• Marenzi G, Assanelli E, Marana I, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med. 2006;354(26):2773–2782.
   PubMed Web of Science ®Google Scholar
• Weisbord SD, Gallagher M, Jneid H, et al. Outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med. 2018;378(7):603–614.
   PubMed Web of Science ®Google Scholar
• Mehran R, Dangas GD, Weisbord SD. Contrast-associated acute kidney injury. N Engl J Med. 2019;380(22):2146–2155.
   PubMed Web of Science ®Google Scholar
• Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348(6):491–499.
   PubMed Web of Science ®Google Scholar
• Stacul F, van der Molen AJ, Reimer P, et al. Contrast induced nephropathy: updated ESUR contrast media safety committee guidelines. Eur Radiol. 2011;21(12):2527–2541.
   PubMed Web of Science ®Google Scholar
• Kelly AM, Dwamena B, Cronin P, et al. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med. 2008;148(4):284–294.
   PubMed Web of Science ®Google Scholar
• Subramaniam RM, Suarez-Cuervo C, Wilson RF, et al. Effectiveness of prevention strategies for Contrast-Induced nephropathy: a systematic review and meta-analysis. Ann Intern Med. 2016;164(6):406–416.
   PubMed Web of Science ®Google Scholar
• Benko A, Fraser-Hill M, Magner P, et al. Canadian association of radiologists: consensus guidelines for the prevention of contrast-induced nephropathy. Can Assoc Radiol J. 2007;58(2):79–87.
   PubMed Web of Science ®Google Scholar
• Meschi M, Detrenis S, Savazzi G. [Contrast-induced nephropathy. Current concepts and propositions for Italian guidelines]. Recenti Prog Med. 2008;99(3):155–162.
   PubMedGoogle Scholar
• Joannidis M, Druml W, Forni LG, et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the working group for nephrology, ESICM. Intensive Care Med. 2010;36(3):392–411.
   PubMed Web of Science ®Google Scholar
• Reed MC, Moscucci M, Smith DE, et al. The relative renal safety of iodixanol and low-osmolar contrast media in patients undergoing percutaneous coronary intervention. Insights from blue cross blue shield of Michigan Cardiovascular Consortium (BMC2). J Invasive Cardiol. 2010;22(10):467–472.
   PubMed Web of Science ®Google Scholar
• Ronco C, Maioli M, Lorusso V, et al. [Contrast-induced nephropathy: the VIKISAFE study group statement]. G Ital Nefrol. 2012;29(2):183–204.
   PubMedGoogle Scholar
• Ad-Hoc Working Group of EEBP, Fliser D, Laville M, et al. A European Renal Best Practice (ERBP) position statement on the kidney disease improving global outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant. 2012;27(12):4263–4272.
   PubMed Web of Science ®Google Scholar
• Ohno I, Hayashi H, Aonuma K, et al. Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version. JSN, JRS, and JCS joint working group. Jpn J Radiol. 2013;31(8):546–584.
   PubMed Web of Science ®Google Scholar
• Owen RJ, Hiremath S, Myers A, et al. Canadian association of radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012. Can Assoc Radiol J. 2014;65(2):96–105.
   PubMed Web of Science ®Google Scholar
• Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124(23):e574–e651.
   PubMed Web of Science ®Google Scholar
• Berkseth RO, Kjellstrand CM. Radiologic contrast-induced nephropathy. Med Clin North Am. 1984;68(2):351–370.
   PubMed Web of Science ®Google Scholar
• van der Molen AJ, Reimer P, Dekkers IA, et al. Post-contrast acute kidney injury – part 1: definition, clinical features, incidence, role of contrast medium and risk factors: recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol. 2018;28(7):2845–2855.
   PubMedGoogle Scholar
• de Laforcade L, Bobot M, Bellin MF, et al. Kidney and contrast media: common viewpoint of the French Nephrology Societies (SFNDT, FIRN, CJN) and the French Radiological Society (SFR) following ESUR guidelines. Diagn Interv Imaging. 2021;102(3):131–139.
   PubMed Web of Science ®Google Scholar
• Davenport MS, Perazella MA, Yee J, et al. Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Radiology. 2020;294(3):660–668.
   PubMed Web of Science ®Google Scholar
• Davenport MS, Cohan RH, Khalatbari S, et al. The challenges in assessing contrast-induced nephropathy: where are we now? Am J Roentgenol. 2014;202(4):784–789.
   PubMed Web of Science ®Google Scholar
• Kodzwa R. ACR manual on contrast media: 2018 updates. Radiol Technol. 2019;91(1):97–100.
   PubMed Web of Science ®Google Scholar
• Lautin EM, Freeman NJ, Schoenfeld AH, et al. Radiocontrast-associated renal dysfunction: a comparison of lower-osmolality and conventional high-osmolality contrast media. Am J Roentgenol. 1991;157(1):59–65.
   PubMed Web of Science ®Google Scholar
• Ren L, Wang P, Wang Z, et al. Hypotonic contrast media is more toxic than isotonic contrast media on endothelial cells in vivo and in vitro. Mol Med Rep. 2017;16(4):4334–4340.
   PubMed Web of Science ®Google Scholar
• Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol. 2005;95(1):13–19.
   PubMed Web of Science ®Google Scholar
• Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105(19):2259–2264.
   PubMed Web of Science ®Google Scholar
• Tong GE, Kumar S, Chong KC, et al. Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration. Abdom Radiol. 2016;41(1):91–99.
   PubMed Web of Science ®Google Scholar
• McDonald JS, Leake CB, McDonald RJ, et al. Acute kidney injury after intravenous versus intra-arterial contrast material administration in a paired cohort. Invest Radiol. 2016;51(12):804–809.
   PubMed Web of Science ®Google Scholar
• Chaudhury P, Armanyous S, Harb SC, et al. Intra-arterial versus intravenous contrast and renal injury in chronic kidney disease: a propensity-matched analysis. Nephron. 2019;141(1):31–40.
   PubMed Web of Science ®Google Scholar
• Schönenberger E, Martus P, Bosserdt M, et al. Kidney injury after intravenous versus intra-arterial contrast agent in patients suspected of having coronary artery disease: a randomized trial. Radiology. 2019;292(3):664–672.
   PubMed Web of Science ®Google Scholar
• Gutierrez NM, Newhouse JH. Maximum arterial contrast concentrations with computed tomography and left ventriculography: implications for contrast nephrotoxicity risk. J Comput Assist Tomogr. 2017;41(6):976–982.
   PubMed Web of Science ®Google Scholar
• Sgura FA, Bertelli L, Monopoli D, et al. Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST-elevation-myocardial infarction. Circ Cardiovasc Interv. 2010;3(5):491–498.
   PubMed Web of Science ®Google Scholar
• Wang Z, Ren K. Evaluation of iodine contrast-induced acute kidney injury via different injection routes using BOLD-MRI. Ren Fail. 2019;41(1):341–353.
   PubMed Web of Science ®Google Scholar
• Zhang J, Guo Y, Jin Q, et al. Meta-analysis of rosuvastatin efficacy in prevention of contrast-induced acute kidney injury. Drug Des Devel Ther. 2018;12:3685–3690.
   PubMed Web of Science ®Google Scholar
• Wang XL, Zhang T, Hu LH, et al. Comparison of effects of different statins on contrast-induced acute kidney injury in rats: histopathological and biochemical findings. Oxid Med Cell Longev. 2017;2017:6282486.
   PubMed Web of Science ®Google Scholar
• Zhou X, Dai J, Xu X, et al. Comparative efficacy of statins for prevention of contrast-induced acute kidney injury in patients with chronic kidney disease: a network meta-analysis. Angiology. 2019;70(4):305–316.
   PubMed Web of Science ®Google Scholar
• Hall KA, Wong RW, Hunter GC, et al. Contrast-induced nephrotoxicity: the effects of vasodilator therapy. J Surg Res. 1992;53(4):317–320.
   PubMed Web of Science ®Google Scholar
• Jeong BY, Lee HY, Park CG, et al. Oxidative stress caused by activation of NADPH oxidase 4 promotes contrast-induced acute kidney injury. PLOS One. 2018;13(1):e0191034.
   PubMed Web of Science ®Google Scholar
• Hussien NI, Sorour SM, El-Kerdasy HI, et al. The glucagon-like peptide-1 receptor agonist exendin-4, ameliorates contrast-induced nephropathy through suppression of oxidative stress, vascular dysfunction and apoptosis independent of glycaemia. Clin Exp Pharmacol Physiol. 2018;45(8):808–818.
   PubMed Web of Science ®Google Scholar
• Lin HH, Lee TS, Lin SJ, et al. DDAH-2 alleviates contrast medium iopromide-induced acute kidney injury through nitric oxide synthase. Clin Sci. 2019;133(23):2361–2378.
   Web of Science ®Google Scholar
• Lin Q, Li S, Jiang N, et al. PINK1-parkin pathway of mitophagy protects against contrast-induced acute kidney injury via decreasing mitochondrial ROS and NLRP3 inflammasome activation. Redox Biol. 2019;26:101254.
   PubMed Web of Science ®Google Scholar
• Caiazza A, Russo L, Sabbatini M, et al. Hemodynamic and tubular changes induced by contrast media. Biomed Res Int. 2014;2014:578974.
   PubMed Web of Science ®Google Scholar
• Heyman SN, Rosen S, Rosenberger C. Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy. Clin J Am Soc Nephrol. 2008;3(1):288–296.
   PubMed Web of Science ®Google Scholar
• Lamby P, Krüger-Genge A, Franke RP, et al. Effect of iodinated contrast media on the oxygen tension in the renal cortico-medullary region of pigs. Clin Hemorheol Microcirc. 2019;73(1):261–270.
   PubMedGoogle Scholar